Skip to content

Clinical trials

Coronary Disease trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Country / region: Finland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062
20071
20082
20182
20191
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status4
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Eastern Finland2
Amgen1
Boehringer Ingelheim1
Hoffmann-La Roche1
Kanta-Häme Central Hospital1
Markus Perola1
Orion Corporation, Orion Pharma1
Paijat-Hame Hospital District1
Rehabilitation Foundation, Finland1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease13
Diabetes Mellitus, Type 23
Cardiovascular Diseases2
Inflammation2
Arrhythmias, Cardiac1
Cerebrovascular Disorders1
Diabetes Mellitus1
Erectile Dysfunction1
Genetic Risk Score1
Heart Failure1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.